Samsrita Labs Ltd.
Snapshot View

View in App

Prices View details >>

19.00 -0.46 ▼-2.4%

22 March 2023, 09:23:00 AM
Volume: 197

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.drhlsl.com
Market Cap 28.82 Cr.
Enterprise Value(EV) 31.71 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.03 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 18.91 Trailing Twelve Months Ending 2022-12
Industry PE 46.11 Trailing Twelve Months Ending 2022-12
Book Value / Share 8.94 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.18 Calculated using Price: 19.46
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.48 Cr. 14,808,706 Shares
FaceValue 10
Company Profile
Dr Habeebullah Life Sciences with its group Companies has established platforms in the areas of Stem Cell Research and Therapy, New Drug Discovery, Molecular Prognosis and Diagnostics services, CRO, Stem Cell focused Super Specialty Hospital, RNA Interference Technology and Medical Devices.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.36%
1 Week
-14.41%
1 Month
-27.48%
3 Month
-37.60%
6 Month
-31.28%
1 Year
-29.63%
2 Year
-53.26%
5 Year
-58.74%
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 1.78 0.72 0.38 -5.26 -10.93 -18.92 -15.29 -6.35 11.94
Return on Capital Employed (%) 1.81 0.73 0.38 -5.25 -10.08 -16.44 -13.30 -5.41 9.95
Return on Assets (%) 1.58 0.52 0.24 -4.56 -9.86 -15.60 -11.76 -4.51 8.71

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 4 4 4 8 12 13 12 12 13 13
Non Curr. Liab. 0 0 0 0 0 0
Curr. Liab. 0 3 2 0 0 2 4 5 4 4
Minority Int.
Equity & Liab. 4 6 6 8 12 15 17 17 17 17
Non Curr. Assets 1 0 0 5 8 9 10 10 10 10
Curr. Assets 3 6 5 3 4 6 7 7 7 7
Misc. Exp. not W/O
Total Assets 4 6 6 8 12 15 17 17 17 17

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 4 4 1 1 2 1 0 0 0
Other Income 0 0 0 0 0 0 0 2 2
Total Income 0 4 4 1 1 2 2 0 2 2
Total Expenditure 0 -4 -4 -2 -2 -4 -3 -1 0 0
PBIDT 0 0 0 0 -1 -2 -2 -1 2 2
Interest 0 0
Depreciation 0 0 0 0
Taxation
Exceptional Items
PAT 0 0 0 0 -1 -2 -2 -1 2 2
Adjusted EPS 0 0 0 0 -1 -2 -1 -1 1 1

Cash Flow View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 0 0 -3 -3 -1 0 0
Cash Fr. Inv. -1 1 -5 -1 -1 -1 0
Cash Fr. Finan. 1 5 5 4 2 1 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 58.27 58.27 58.27 58.27 58.27 52.87 52.87 52.87 52.87
Public 41.73 41.73 41.73 41.73 41.73 47.13 47.13 47.13 47.13
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 01 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Approved Un-Audited Financial Results For The Quarter Ended 31.12.2022
Tue, 31 Jan 2023
Approval Of Un-Audited Financial Results For The Quarter Ended 31.12.2022.
Approval of un-audited financial results for the quarter ended 31.12.2022.
Mon, 23 Jan 2023
Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 31.12.2022.
Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 inter alia to consider and approve Unaudited financial results for the quarter ended 31.12.2022.

Technical Scans View Details >>

Tue, 21 Mar 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing 52 Week Low Close Crossing 52 Week Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 960.10 +0.4%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,433.40 +0.3%
Divi's Laboratories Ltd. 73,553.38 2,782.00 +0.5%
Cipla Ltd. 69,632.88 857.05 -0.6%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,260.00 -0.3%
Torrent Pharmaceuticals Ltd. 51,277.87 1,518.95 +0.3%
Zydus Lifesciences Ltd. 48,378.30 479.20 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 960.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,433.40 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,782.00 +0.5%
Cipla Ltd. Consolidated 2022-12 26.39 857.05 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,260.00 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,518.95 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 479.20 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 960.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,433.40 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,782.00 +0.5%
Cipla Ltd. Consolidated 2022-12 3.07 857.05 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,260.00 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,518.95 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 479.20 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 960.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,433.40 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,782.00 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 857.05 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.00 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.95 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.20 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 960.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,433.40 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,782.00 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 857.05 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.00 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.95 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.20 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 960.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,433.40 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,782.00 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 857.05 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.00 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.95 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.20 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 960.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,433.40 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,782.00 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 857.05 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.00 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.95 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.20 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 960.10 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,433.40 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,782.00 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 857.05 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.00 -0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.95 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.20 +0.2%

FAQ's On Samsrita Labs Ltd.

What is Samsrita Labs share price?
Can I buy Samsrita Labs shares now?
What is the Market Cap of Samsrita Labs?
What are the key metrics to analyse Samsrita Labs?
What is the 52 Week High and Low of Samsrita Labs?
What is the trend of Samsrita Labs share price?